The HLA-DR Expression on Monocytes in Acute Dengue Infection by Intansari, Umi Solekhah et al.
39
Umi Solekhah Intansari, et al, The HLA-DR Expression on Monocytes in Acute Dengue InfectionTMJ Vol. 02 No. 1 39-44
The HLA-DR Expression on Monocytes in Acute Dengue
Infection
Umi Solekhah Intansari1,*, Muhammad Ilham Bin Azib2, Mohd Nazirul Shareef bin Mohd
Ridhwan2, Ida Safitri Laksanawati3
1Department of Clinical Pathology, Faculty of Medicine, Universitas Gadjah Mada, Yogyakarta.
2Undergraduate Program of Medicine, Faculty of Medicine, Universitas Gadjah Mada, Yogyakarta.
3Department of Pediatric, Dr. Sardjito General Hospital, Yogyakarta.
*Corresponding author: umintasari2003@yahoo.com
ABSTRACT
Introduction: Dengue is the most common disease of mosquito-borne infection. According to the World
Health Organization7 , it is estimated that 50 million cases of dengue infection have been reported annually.
Macrophages and monocyte are thought to play an important role in dengue infection both as primary
targets of viral infection and as a source of immunomodulatory cytokines. When monocytes are infected
by dengue viruses, it processed the virus by lyses it and expressed the antigen on its surface membrane
bind together with HLA class II molecules. HLA-DR-expressing monocytes in acute dengue patients
especially the intensity is still poorly understood. Measurement of at difference days of infection will give
an evidence about the role of monocytes in dengue pathogenesis
Objectives: To observe the kinetics on percentage of HLA-DR-expressing monocytes and the median of
HLA-DR expression intensity in acute dengue infection.
Methods: This research was an observational type study conducted by cross sectional method towards
all the dengue patients in Dr. Sardjito’s General Hospital. Blood samples were drawn from 32 acute
dengue infected patients from Day 1 to Day 6th. The HLA-DR expression was measured flow
cytometrically using FACS Calibur.
Results: The data showed that the mean difference in acute dengue infection from Day 1 to Day 6 is
not significant with the p-value larger than 0.05, (p>0.05).
Conclusion: The peak level of activated HLA-DR monocyte was at day 2 and then decreasing until day
6. There were no significant changes in percentage of HLA-DR-expressing monocytes from the day 1
to the day 6 and the median intensity of HLA-DR expression in acute dengue infection.
Keywords HLA-DR-expressing monocytes, Acute Dengue Infection
INTISARI
Pendahuluan: Infeksi Dengue adalah penyakit tersering dikalangan penyakit yang mengunakan
nyamuk sebagai vektor. Diperkirakan 50 juta kasus infeksi dengue terjadi setiap tahun. Makrofag dan
monosit memainkan peran yang penting dalam infeksi dengue sebagai target primer bagi infeksi
dan juga sebagai sumber sitokin immunomodulator. Apabila monosit terinfeksi oleh virus dengue,
monosit akan memproses virus tersebut dan mengekspresi antigen pada permukaan sel bersama
molekul HLA kelas II. Pengukuran aktivasi monosit pada infeksi dengue akut akan memberikan
informasi mengenai peranan monosit dalam patogenesis infeksi dengue.
Tujuan:Tujuan penelitian ini adalah untuk mengobservasi kinetic dari persentasi monosit yang teraktivasi
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melalui ekspresi HLA-DR pada demam denggi akut hari pertama hingga hari keenam.
Metode: Penelitian ini dilakukan dalam metode penelitian observational secara cross-sectional.
Hasil: Data menunjukkan bahawa perbezaan purata pada hari-hari demam denggi adalah tidak
signifikan dengan nilai p diatas batas 0.05, (p>0.05).
Simpulan: Secara keseluruhannya, antara hari pertama hingga hari keenam, secara statistiknya
menunjukkan bahawa tiada perbedaan yang signifikan pada persentasi monosit yang teraktivasi.
Kata kunci: Ekspresi HLA-DR pada monosit, Demam Dengue Akut
INTRODUCTION
Dengue is the most common disease of
mosquito-borne infection. According to the
World Health Organization1, it is estimated that
50 million cases of dengue infection have been
reported annually. The prevalence of dengue
has grown dramatically in recent decades. The
disease is now endemic in more than 100
countries in Africa, the Americas, the Eastern
Mediterranean, Southeast Asia and the Western
Pacific.
Dengue fever is an acute infectious disease
caused by four serotypes of dengue virus (DV). It is
characterized by biphasic fever, myalgia, headache,
and pain in various parts of the body, rash,
lymphadenopathy, and leucopenia2. Dengue fever
is self-limited, but, it will progress to DHF or Dengue
Shock Syndrome (DSS) in certain conditions, which
is heterotypic infection of DV. Dengue hemorrhagic
fever is a severe febrile illness characterized by
abnormalities of homeostasis and increased
vascular permeability, and severe progression may
result in DSS. Dengue shock syndrome is a form of
hypovolemic shock that is associated clinically with
hemoconcentration and which might lead to death
if appropriate care is not given. The other
characteristic features of DHF include that the
increase in vascular permeability is without
morphological damage to the capillary
endothelium, altered number and functions of
leucocytes and increase hematocrit4.
After DV infection, there is a continuum from
mild DF to severe DHF or DSS. It has been estimated
that only 4-6% of individuals with secondary
infection develop severe DHF disease4.
Monocytes appear to be important in the
pathogenesis of dengue infection. They are
thought to be the most active sites of virus
replication during dengue infection. Monocytes
ingest the pathogens, digest them and present their
antigens with major histocompatibility complex
(MHC) class II molecules on their cell membranes
to B lymphocytes and T cells to generate antigen-
specific immune response. Monocytes again come
into play as they opsonize the virus or the cell with
antibodies attached to control and eliminates the
virus.
A number of pathogens, including DV, subvert
monocytes and use them for their replication
increasing severity of the damage to body3. The
extent of DV replication during the early periods
of infection may determine clinical outcomes,
which may be from asymptomatic infection to
febrile illness, DF, to life-threatening disease, DHF/
DSS. The impact of DV infection on innate immunity
may be the determining factor.
The cells of macrophage-lineage, interstitial
dendritic cell (DC) and Langhans cell (LC) constitute
the first line of the innate host defense against
invading DV in skin where it replicates after the
initial bite by infected mosquito. When monocytes
phagocyte a dengue virus, they process the virus
by lyses it and then transported the lyses peptide
to the surface of cell membranes and expressed it
at the MHC class two molecules.
The complex of MHC class two molecules and
dengue viral peptides will then be present to T and
B cells so then an adaptive immune system will be
initiated. The expression of HLA-DR in monocytes
therefore is important as a marker for the HLA-DR-
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expressing monocytes. Measurement of HLA-DR-
expressing monocytes at difference days of
infection may help in prognosis of dengue
disease and may be correlated with severity of
the disease.
RESEARCH METHOD
This research was designed as observational
cross sectional. 32 patients who are under
treatment at the internal medicine’s department
in Dr. Sardjito Hospital, Yogyakarta, were recruited
as the subjects of the study. The inclusion criteria
of the research subjects were patients who were
suspected of having dengue fever with NS-1
positive test and the age more than 14 years.
The exclusion criteria of the research subjects
were those who have chronic disease other than
dengue infection. Patient’s who fulfilled the
inclusion criteria and did not have any of the
exclusion criteria, were given informed consent
and the procedure in this study was explained to
them. After they agreed and signed the informed
consent form, 3 ml of intravenous blood sample
was taken aseptically from Day 1 to Day 6. The blood
sample was kept in a room temperature between
20o C – 25o C. The sample was sent to the Pathology
Clinic Laboratory for complete blood test using the
hematology analyzer and analysis of HLA-DR
activation marker was done by flow cytometry test.
For flow-cytometry examination, for every
specimen, 50 uL of whole blood was inserted
into a tube (12 x 75mm), EDTA anticoagulant with
the correct amount was added. Ten uL CD HLADR
PE / CD45 per CP antibody which is fluorescently
labeled was added. Mixture was vortex slowly
and incubated for 15 minutes in a dark room at
the temperature of 20o – 25o C. Fifty uL 10x FACS
Lysing Solution was diluted with 450 uL aquadest.
450 uL 1x FACS Lysing Solution was added to lyses
the erythrocyte. Mixture was vortex slowly and
incubated for 15 minutes in a dark room at the
temperature of 20o – 25o C. The sample was
analyzed using the FACS Calibur Flow cytometer.
Population of monocytes was determined by the
cell granulation and expression of CD 45.
Distribution of data was determined by using
Probability-probability test. Descriptive statistical
analysis was done for each day of acute dengue
infection which include mean, standard deviation
and minimum and maximum percentage of HLA-
DR-expressing monocytes. Means difference in
percentage of HLA-DR-expressing monocytes was
calculated by using ANOVA. If the p-value is below
0.05, p<0.05, the mean differences is significant.
RESULTS AND DISCUSSIONS
From this study, out of 32 subjects, 17
subjects were classified as having dengue fever
(DF) and the rest, 15 subjects classified having
dengue hemorrhagic fever (DHF). This
classification is done by using WHO guidelines
of dengue infection. Table 1 shows the
classification of dengue patient in this study.
Table 1. Classification of Dengue Infection in subject
The distribution of data in this study is normal
from day 1 to day 6. Figure 1 is the probability-
probability plot for day 1 that represents the normal
distribution of data for day 1.
Figure 1. The Probability-Probability Plot of Day
1 on Percentage of HLA-DR-expressing
monocytes
42
TMJ Vol. 02 No. 1 39-44
Table 2. Descriptive Analysis of HLA-DR-
expressing monocytes
Table 2 shows the minimum, maximum,
mean and standard deviation of HLA-DR-
expressing monocytes from Day 1 to Day 6 of
acute dengue infection. The maximum
percentage of HLA-DR-expressing monocytes
was in Day 2, which is 99.52%. However the
difference is not significant compare to other
days, for example at Day 1, the maximum
percentage of HLA-DR-expressing monocytes
was 99.43% and it differs only 0.09%. While for
the minimum percentage of HLA-DR-expressing
monocytes was in Day 6 which is 50.0%, and the
difference is big compare to other days thus,
produce the highest standard deviation for Day
3 compare to other days of infection. For the
mean, percentage of HLA-DR-expressing
monocytes was lowest at Day 3 and highest at
Day 1. From table 2 also, there is a trend that
shows a decreasing percentage of HLA-DR-
expressing monocytes from Day 1 to Day 3, which
is from 93.27% to 90.15%. The percentages of
HLA-DR-expressing monocytes increased again
at Day 4 which is 93.17%. For the rest of Day 5
and Day 6, the percentage of HLA-DR-expressing
monocytes slightly decreased.
For means comparison, the mean difference
between days of infection is not significant with
p value more than 0.05, (p>0.05).
Overall percentage of HLA-DR-expressing
monocytes in acute dengue infection from our
study is around 90% to 93%. This percentage is
very high compare to our control negative subject
which is only 22%. It means that there is a very
rapid activation of monocytes during acute
Figure 2. Percentage of HLA-DR-expressing
monocytes Activated during Acute
Dengue Infection
dengue infection. We suggest that this condition
happen due to the immunopathogenesis of this
disease itself. Many studies have demonstrated
that monocytes are the target cells for dengue
viral replication. Chaturvedi4 (2006) has shown
that the dengue virus replication rate is higher
in monocytes compare to peripheral B cells.
When monocytes were infected by dengue virus,
they become activated. So, the activation of
monocytes is rapid because the dengue virus
attacks the cells itself. Means the activation of
monocytes are directly related to dengue virus
infection or dengue virus severity.
Figure 3. The Mean of Median Activated Mono-
cyte
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From figure 3 there was a decrease of
data(mean) from day 2-3. An increase from day 3-4
and decrease after that from day 4-6. The highest
amount of HLA-DR activated monocyte is at day 2.
The analysis of variance (ANOVA) is done since we
want to see the difference of HLA-DR activated
monocyte for multiple days from day 2-6. From the
median descriptive statistic we can see at day 2
there is a peak amount of activated monocyte. This
is in line with a research which said that maximal
infection rate was measured for wild type Asian
genome (D2/IC-30P-A) at 48 h post infection7. They
also uses flowcytometry HLA-DR to detect the
manocyte derived macrophage7.
Activation of monocytes by expressing HLA-
DR molecules on its surface membrane and by
releasing several cytokines is needed as part as our
immune response to infection. One of the
functions of monocytes is they serve as antigen
presenting cell (APC)8. They present exogenous
peptides processed as HLA-DR and bind it to the T
cell receptors (TCR) of T cells. In a normal immune
response, when there is a systemic infection, a
large numbers of monocytes need to be activated.
If there is low percentage of HLA-DR-expressing
monocytes, or the expression of HLA-DR by
monocytes is less in a systemic infection or systemic
inflammation process, it will lead to poor outcomes
of the patient. It has been proven by Haveman6
(2006) that HLA-DR expressed by monocytes has
been decreased in non-survivors patient with
systemic inflammation process. In patients who
have multiple organ failure and having severe
inflammatory process reaction, the level of HLA-
DR express by monocytes is decreasing6. It is then
suggesting that in normal physiological condition
where our immune response is capable to act
against infection and inflammatory response, it is
therefore a normal to have a high level of HLA-DR-
expressing monocytes or increasing level of HLA-
DR-expressing monocytes. This condition has also
been supported from a research by Haveman6 and
colleague that shows the patient who increase
expression of HLA-DR in systemic inflammation
survive the condition.
The expression of HLA-DR by monocytes is
regulated by certain mediators such as interferon-
ã (IFN-ã) and tumor necrosis factor-á (TNF-á). There
could be a more details explanations in molecular
levels on how immunopathogenesis of dengue can
influence the expression of HLA-DR in monocytes.
Birle3 (2003) have stated in his journal that TNF-á
can down regulate the expression of HLA-DR in
monocytes. Green5 (1999) demonstrated that the
level of TNF-á was different in DF and DHF. The
TNF-á level in DHF was higher compare to DF. In
DHF, the level of TNF-á was high at beginning which
is at day 1 and decrease steadily from day 2 to day 6
compare to DF, the level of TNF-á is low at day 1
and highest at day 3 and decrease after day 3.
For the mean comparison, our study shows
that there is no significant in mean difference
between days of acute dengue infection. If we
see from the data, there are no big changes occur
in the percentage of HLA-DR-expressing
monocytes from Day 1 to the Day 6 of acute
dengue infection. The mean on percentage of
HLA-DR-expressing monocytes throughout the
six day of infection are around 90% to 93%. We
suggest that the percentage of HLA-DR-
expressing monocytes will remain high during
acute period. Our study has limitation because
we did not observe the factors or mediators that
may affect the expression of HLA-DR in
monocytes. This condition also related with a
study from Green5 (1999) that shows IFN-ã
increase rapidly during early period of dengue
infection and remain high for several days
before it decrease suddenly.
Birle3 (2003) in his article stated that IFN-ã
increase expression of HLA-DR in monocytes.
The level of IFN-ã in dengue infection was
similar with the levels of TNF-á. It increase
rapidly at day 1 and reach maximum level at day
3 and decrease after day 3. It may suggest that
maybe the high concentration of IFN-ã at day 3
will cause the expression of HLA-DR increase at
day 4, but it is not significant. However, this
opinion is contradicted to previous explanation
because the levels of TNF and IFN reach highest
point at same day which was at day 3. Therefore,
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we suggest that IFN and TNF alone cannot be a
standard to monitoring the levels of HLA-DR
expression in monocytes. There could be other
explanations that can show on how HLA-DR is
regulated.
CONCLUSION
Overall, it is statistically proven that there
are no significant changes in percentage of HLA-
DR-expressing monocytes from the day 1 to the
day 6 in dengue infection. Percentage of HLA-
DR-expressing monocytes in dengue infection
remains high during acute dengue infection.
SUGGESTION
There could be more explanation on kinetics
of HLA-DR-expressing monocytes if the
researcher also observed factors that can affect
the expression of HLA-DR molecules.
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